Literature DB >> 25802347

Assessing sexual symptoms and side effects in adolescents.

Amir Levine1, Eleanor McGlinchey2.   

Abstract

Keywords:  CAMS; SSRI; TADS; adolescence; sexual side effects; sexual symptoms

Mesh:

Substances:

Year:  2015        PMID: 25802347      PMCID: PMC8194463          DOI: 10.1542/peds.2014-3003

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  6 in total

Review 1.  Selective serotonin reuptake inhibitor-induced sexual dysfunction in adolescents: a review.

Authors:  Alexander M Scharko
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-09       Impact factor: 8.829

2.  Ssri-induced sexual dysfunction in adolescents.

Authors:  Alexander M Scharko; William G Reiner
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-09       Impact factor: 8.829

3.  Depressive symptoms as a longitudinal predictor of sexual risk behaviors among US middle and high school students.

Authors:  Jocelyn A Lehrer; Lydia A Shrier; Steven Gortmaker; Stephen Buka
Journal:  Pediatrics       Date:  2006-07       Impact factor: 7.124

4.  Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline.

Authors:  J G Modell; C R Katholi; J D Modell; R L DePalma
Journal:  Clin Pharmacol Ther       Date:  1997-04       Impact factor: 6.875

5.  Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

Authors:  John March; Susan Silva; Stephen Petrycki; John Curry; Karen Wells; John Fairbank; Barbara Burns; Marisa Domino; Steven McNulty; Benedetto Vitiello; Joanne Severe
Journal:  JAMA       Date:  2004-08-18       Impact factor: 56.272

6.  Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety.

Authors:  John T Walkup; Anne Marie Albano; John Piacentini; Boris Birmaher; Scott N Compton; Joel T Sherrill; Golda S Ginsburg; Moira A Rynn; James McCracken; Bruce Waslick; Satish Iyengar; John S March; Philip C Kendall
Journal:  N Engl J Med       Date:  2008-10-30       Impact factor: 91.245

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.